Autoantibody screening in Guillain–Barré syndrome

BACKGROUND: Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lleixà, Cinta, Martín-Aguilar, Lorena, Pascual-Goñi, Elba, Franco, Teresa, Caballero, Marta, de Luna, Noemí, Gallardo, Eduard, Suárez-Calvet, Xavier, Martínez-Martínez, Laura, Diaz-Manera, Jordi, Rojas-García, Ricard, Cortés-Vicente, Elena, Turón, Joana, Casasnovas, Carlos, Homedes, Christian, Gutiérrez-Gutiérrez, Gerardo, Jimeno-Montero, María Concepción, Berciano, José, Sedano-Tous, Maria José, García-Sobrino, Tania, Pardo-Fernández, Julio, Márquez-Infante, Celedonio, Rojas-Marcos, Iñigo, Jericó-Pascual, Ivonne, Martínez-Hernández, Eugenia, Morís de la Tassa, Germán, Domínguez-González, Cristina, Juárez, Cándido, Illa, Isabel, Querol, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559393/
https://www.ncbi.nlm.nih.gov/pubmed/34719386
http://dx.doi.org/10.1186/s12974-021-02301-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559393/
https://www.ncbi.nlm.nih.gov/pubmed/34719386
http://dx.doi.org/10.1186/s12974-021-02301-0

Ejemplares similares